PMID- 22227562 OWN - NLM STAT- MEDLINE DCOM- 20120625 LR - 20211109 IS - 1535-4989 (Electronic) IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 46 IP - 5 DP - 2012 May TI - Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. PG - 668-76 LID - 10.1165/rcmb.2011-0074OC [doi] AB - Supplemental oxygen is frequently prescribed. However, prolonged exposure to high concentrations of oxygen causes hyperoxic acute lung injury (HALI), which manifests as acute respiratory distress syndrome in adults and leads to bronchopulmonary dysplasia in newborns (NBs). Nitric oxide (NO), NO synthases (NOSs), and angiopoietin (Ang) 2 have been implicated in the pathogenesis of HALI. However, the mechanisms of the contributions of NOS/NO and the relationship(s) between NOS/NO and Ang2 have not been addressed. In addition, the relevance of these moieties in adults and NBs has not been evaluated. To address these issues, we compared the responses in hyperoxia of wild-type (NOS [+/+]) and NOS null (-/-) young adult and NB mice. When compared with NOS2(+/+) adult controls, NOS2(-/-) animals manifest exaggerated alveolar-capillary protein leak and premature death. These responses were associated with enhanced levels of structural cell death, enhanced expression of proapoptotic regulatory proteins, and Ang2. Importantly, silencing RNA knockdown of Ang2 decreased the levels of cell death and the expression of proapoptotic mediators. These effects were at least partially NOS2 specific, and were development dependent, because survival was similar in adult NOS3(+/+) and NOS3(-/-) mice and NB NOS2(+/+) and NOS2(-/-) mice, respectively. These studies demonstrate that NOS2 plays an important protective role in HALI in adult animals. They also demonstrate that this response is mediated, at least in part, by the ability of NOS2 to inhibit hyperoxia-induced Ang2 production and thereby decrease Ang2-induced tissue injury. FAU - Bhandari, Vineet AU - Bhandari V AD - Division of Perinatal Medicine, Yale University School of Medicine, Department of Pediatrics, Children's Hospital, 20 York Street, New Haven, CT 06520-8057, USA. vineet.bhandari@yale.edu FAU - Choo-Wing, Rayman AU - Choo-Wing R FAU - Harijith, Anantha AU - Harijith A FAU - Sun, Huanxing AU - Sun H FAU - Syed, Mansoor Ali AU - Syed MA FAU - Homer, Robert J AU - Homer RJ FAU - Elias, Jack A AU - Elias JA LA - eng GR - HL-64642/HL/NHLBI NIH HHS/United States GR - K08 HL074195/HL/NHLBI NIH HHS/United States GR - HL-61904/HL/NHLBI NIH HHS/United States GR - P01 HL056389/HL/NHLBI NIH HHS/United States GR - HL-85103/HL/NHLBI NIH HHS/United States GR - HL-56389/HL/NHLBI NIH HHS/United States GR - HL-74195/HL/NHLBI NIH HHS/United States GR - R01 HL085103/HL/NHLBI NIH HHS/United States GR - P50 HL056389/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120106 PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Angiopoietin-2) RN - 0 (RNA, Small Interfering) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, mouse) SB - IM MH - Angiopoietin-2/*physiology MH - Animals MH - Bronchoalveolar Lavage Fluid MH - Gene Expression Regulation, Enzymologic MH - Hyperoxia/*complications MH - Lung Injury/enzymology/*etiology MH - Mice MH - Mice, Knockout MH - Nitric Oxide Synthase Type II/genetics/*metabolism MH - RNA, Small Interfering PMC - PMC3359903 EDAT- 2012/01/10 06:00 MHDA- 2012/06/26 06:00 PMCR- 2013/05/01 CRDT- 2012/01/10 06:00 PHST- 2012/01/10 06:00 [entrez] PHST- 2012/01/10 06:00 [pubmed] PHST- 2012/06/26 06:00 [medline] PHST- 2013/05/01 00:00 [pmc-release] AID - rcmb.2011-0074OC [pii] AID - 2011-0074OC [pii] AID - 10.1165/rcmb.2011-0074OC [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 2012 May;46(5):668-76. doi: 10.1165/rcmb.2011-0074OC. Epub 2012 Jan 6.